Timothy Hoey
Technik-/Wissenschafts-/F&E-Leiter bei TENAYA THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.05.2024
Aktive Positionen von Timothy Hoey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TENAYA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2017 | - |
Karriereverlauf von Timothy Hoey
Ehemalige bekannte Positionen von Timothy Hoey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | 01.01.2017 |
| Corporate Officer/Principal | 01.01.2005 | 01.01.2016 | |
| AMGEN INC. | Corporate Officer/Principal | - | 01.01.2005 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | - | 14.12.2011 |
| Corporate Officer/Principal | 14.12.2011 | - |
Ausbildung von Timothy Hoey
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Börse
- Insiders
- Timothy Hoey
- Erfahrung